- Home
- TERN vs CGAU Comparison
TERN vs CGAU Comparison
Compare TERN & CGAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TERN | CGAU |
|---|---|---|
| Founded | 2017 | 2002 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 3.9B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TERN | CGAU |
|---|---|---|
| Price | $52.97 | $16.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 3 |
| Target Price | ★ $45.22 | $16.67 |
| AVG Volume (30 Days) | ★ 3.1M | 1.4M |
| Earning Date | 05-14-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.16% |
| EPS Growth | ★ 8.04 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $25.17 |
| Revenue Next Year | N/A | $13.62 |
| P/E Ratio | ★ N/A | $11.74 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.98 | $6.71 |
| 52 Week High | $53.19 | $21.17 |
Technical Indicators
Market Signals| Indicator | TERN | CGAU |
|---|---|---|
| Relative Strength Index (RSI) | 74.51 | 37.94 |
| Support Level | $52.42 | $15.44 |
| Resistance Level | $53.19 | $19.95 |
| Average True Range (ATR) | 0.07 | 0.72 |
| MACD | -0.31 | -0.18 |
| Stochastic Oscillator | 97.30 | 11.20 |
Price Performance
Historical ComparisonAbout TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About CGAU Centerra Gold Inc.
Centerra Gold Inc is principally focused on operating, developing, exploring and acquiring gold and copper properties in North America, Turkey, and other markets world-wide. The company reportable operating segments are Oksut; Mount Milligan; and Molybdenum. It derives maximum revenue from Mount Milligan segment. Geographically, it operates in Turkey, United States, and Canada.